These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Increased expression of IL12B mRNA transcribed from the risk haplotype for Crohn's disease is a risk factor for disease relapse in Japanese patients. Kakuta Y, Kimura T, Negoro K, Kuroha M, Shiga H, Endo K, Kinouchi Y, Shimosegawa T. J Gastroenterol; 2017 Dec; 52(12):1230-1239. PubMed ID: 28229296 [Abstract] [Full Text] [Related]
28. Two independent genetic factors responsible for the associations of the IBD5 locus with Crohn's disease in the Czech population. Hradsky O, Dusatkova P, Lenicek M, Bronsky J, Duricova D, Nevoral J, Vitek L, Lukas M, Cinek O. Inflamm Bowel Dis; 2011 Jul; 17(7):1523-9. PubMed ID: 21674708 [Abstract] [Full Text] [Related]
30. Associations between NRAMP1 Polymorphisms and Susceptibility to Ulcerative Colitis/Crohn's Disease: A Meta-Analysis. Sun M, Zhang L, Shi S. Immunol Invest; 2016 Jul; 45(3):255-70. PubMed ID: 27019053 [Abstract] [Full Text] [Related]
31. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia. Harivenkatesh N, Kumar L, Bakhshi S, Sharma A, Kabra M, Velpandian T, Gogia A, Shastri SS, Biswas NR, Gupta YK. Pharmacol Res; 2017 Jun; 120():138-145. PubMed ID: 28330783 [Abstract] [Full Text] [Related]
35. Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study. Onnie CM, Fisher SA, Pattni R, Sanderson J, Forbes A, Lewis CM, Mathew CG. Inflamm Bowel Dis; 2006 Apr; 12(4):263-71. PubMed ID: 16633048 [Abstract] [Full Text] [Related]
38. MDR1 polymorphisms associated with risk and survival in diffuse large B-cell lymphoma. Hu LL, Yu B, Yang J. Leuk Lymphoma; 2013 Jun; 54(6):1188-93. PubMed ID: 23088763 [Abstract] [Full Text] [Related]